Alzheimer’s disease – Page 3

Alzheimer’s Disease: Navigating Controversies and Shaping Future Strategies

By MedXY 10/10/2025

Recent advances in anti-β amyloid monoclonal antibodies offer promising reductions in Alzheimer’s disease progression but spark debate regarding their clinical impact, cost-effectiveness, and accessibility. Emerging biomarkers and preventive approaches herald a new era in personalized dementia care.

Clinical Updates Neurology news

Clinically Meaningful Changes in Cognitive and Functional Measures Early in Alzheimer’s Disease: Insights from Population-Based Cohorts

By MedXY 09/28/2025

This review synthesizes evidence on clinically meaningful within-patient changes in cognitive and functional assessments among individuals transitioning to mild cognitive impairment (MCI), highlighting implications for clinical trials and early intervention in Alzheimer's disease and related dementias (ADRD).

Clinical Updates Diabetes & Endocrinology Neurology news Specialties

Promising Links Between Diabetes Medications and Alzheimer’s Disease Risk Reduction

By MedXY 09/25/2025

Recent real-world data suggest GLP-1 receptor agonists and SGLT2 inhibitors may lower Alzheimer’s disease risk more effectively than DPP-4 inhibitors, highlighting the need for randomized trials to confirm potential neuroprotective benefits.

Family Medicine & Nutrition Neurology news Specialties

Anti-Inflammatory Diet and Alzheimer’s Disease Mortality: Insights from a National Cohort Study

By MedXY 09/07/2025

Higher adherence to an anti-inflammatory diet is linked to lower all-cause mortality and a trend toward reduced Alzheimer's disease mortality, particularly among men and non-Hispanic Whites, highlighting dietary modification as a potential strategy to mitigate neuroinflammation and AD risk.

Clinical Updates Family Medicine & Nutrition Neurology news Specialties

Genotype-Specific Metabolic Insights and Mediterranean Diet Impact on Dementia Risk and Cognitive Health

By MedXY 09/04/2025

This article explores how genetic variants, plasma metabolites, and Mediterranean diet adherence interplay in modulating dementia risk and cognitive function, highlighting precision nutrition approaches for Alzheimer’s disease prevention.

Family Medicine & Nutrition Medical News Neurology news Specialties

Precision Nutrition: Can the Mediterranean Diet Reduce Alzheimer’s Risk in APOE4 Carriers?

By MedXY 09/04/2025

A large prospective study reveals that adherence to a Mediterranean diet significantly lowers dementia risk, especially in individuals carrying two copies of the APOE4 gene associated with Alzheimer’s disease, highlighting the potential of genetics-informed dietary strategies.

Clinical Updates Neurology news Specialties

Unraveling the Gut–Brain Connection: Tau Propagation via the Vagus Nerve in Alzheimer’s Disease

By MedXY 09/04/2025

Recent research reveals that pathological tau can propagate from the brain to the colon through the vagal efferent pathway in Alzheimer's disease, supporting a novel brain-to-gut axis involvement in disease progression and gut function impairment.

Neurology Specialties

FDA Approves Subcutaneous Lecanemab for Maintenance Treatment in Early Alzheimer’s Disease: A Step Toward More Accessible Care

By MedXY 09/02/2025

The FDA has approved a subcutaneous form of lecanemab for maintenance therapy in early Alzheimer’s, offering similar clinical benefits to IV dosing with improved convenience and safety, potentially transforming patient care delivery.

Clinical Updates news

Therapeutic Potential of 40 Hz Light Stimulation in Alzheimer’s Disease: Mechanisms, Modalities, and Clinical Insights

By MedXY 08/27/2025

This review synthesizes mechanistic, preclinical, and clinical evidence on 40 Hz light stimulation as a novel therapeutic approach to slow Alzheimer's disease progression, highlighting safety, efficacy, and modality comparisons.

Clinical Updates Diabetes & Endocrinology Neurology news Specialties

Obicetrapib Shows Promise in Slowing Alzheimer’s Disease Progression Through Lipid Modulation

By MedXY 08/17/2025

Obicetrapib, a CETP inhibitor, significantly slowed Alzheimer’s disease biomarker progression over 12 months and improved p-tau217 levels in APOE4 carriers while also benefiting lipid profiles in cardiovascular disease patients.

Clinical Updates Neurology news Specialties

Lithium Orotate as a Novel Therapeutic Avenue for Alzheimer’s Disease: Insights from the Latest Nature Study

By MedXY 08/08/2025

A Nature study links lithium deficiency in the brain to Alzheimer’s onset and shows lithium orotate reverses memory loss in mice, offering new hope for Alzheimer’s therapy.

Clinical Updates Neurology news Specialties

Advancing Alzheimer’s Risk Prediction: Multi-Ancestry Polygenic Risk Scores in Hispanic Populations

By MedXY 08/07/2025

Multi-ancestry polygenic risk scores significantly improve Alzheimer’s disease risk prediction in Hispanic populations compared to traditional single-ancestry models and APOE genotyping alone.

Neurology news Specialties

Understanding and Managing Alzheimer’s Disease: A Comprehensive Guide

By MedXY 08/03/2025

An in-depth overview of Alzheimer's disease, covering its causes, symptoms, diagnosis, treatment options, and caregiving strategies.

Clinical Updates Neurology news Specialties

Elevated Risk of Alzheimer’s Disease and Related Dementias in Transfeminine Adults: Insights from a Large Cohort Study

By MedXY 08/02/2025

Recent data reveal that transfeminine adults experience significantly higher prevalence of Alzheimer's disease and related dementias compared to matched cisgender peers, independent of gender-affirming hormone therapy, highlighting urgent needs for targeted research and care strategies.

Medical News Neurology news Specialties

Legacy of Leaded Gasoline: New Evidence Links Childhood and Adult Exposure to Cognitive Impairment in Older Adults

By MedXY 07/30/2025

Recent studies confirm that both childhood and adult lead exposure, especially from gasoline and industrial sources, are associated with increased risk for cognitive decline and dementia in later life.

AI Clinical Updates news Specialties

Demographic Data Gaps in FDA Authorization of AI-Based Devices for Alzheimer’s Disease and Related Dementias

By MedXY 07/30/2025

Limited demographic data transparency in FDA-authorized AI devices for Alzheimer’s may hinder equitable care and generalizability, highlighting a crucial need for improved dataset representativeness and regulatory oversight.

Clinical Updates Family Medicine & Nutrition Neurology news Specialties

Walking and Dietary Interventions Offer Cognitive Protection in APOE ε4 Carriers: New Evidence from Longitudinal and Multinational Trials

By MedXY 07/30/2025

Regular walking and lifestyle interventions slow cognitive decline, especially in APOE ε4 carriers at heightened Alzheimer’s risk, with effects pronounced in women. Evidence underscores the value of simple activity and healthy diet for at-risk older adults.

Clinical Updates Medical News Neurology Specialties

Lecanemab in Community Practice: Real-World Safety and Efficacy for Early Alzheimer’s Disease

By MedXY 07/29/2025

Community-based data suggest lecanemab is safe and effective for early-stage Alzheimer’s, with manageable ARIA rates and infusion reactions, particularly in ApoE4 noncarriers.

Clinical Updates Medical News Neurology Specialties

Alzheimer’s Association Releases First Clinical Guidelines for Blood-Based Biomarkers: Implications for Diagnosis and Practice

By MedXY 07/29/2025

New Alzheimer’s Association guidelines endorse blood-based biomarkers as diagnostic adjuncts, not standalone tests, emphasizing rigorous clinical evaluation and high test accuracy.